|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.03.26 - 10:12
|
Top Wall Street Forecasters Revamp ABM Expectations Ahead Of Q1 Earnings (Benzinga)
|
|
|
ABM (NYSE: ABM) will release Q1 earnings on March 10. Analysts expect EPS of 87 cents and revenue of $2.19B. Stock fell 1.3% on March 8.
Latest Ratings for ABM
DateFirmActionFromTo Dec 2021KeybancMaintainsOverweight Apr 2021KeybancMaintainsOverweight Jun 2020KeybancMaintainsOverweight
View More Analyst Ratings for ABM
View the Latest Analyst Ratings
Importance Rank:
1
read more...
|
|
|
|
|
10.03.26 - 10:12
|
Why Zevra Therapeutics Shares Are Trading Higher By Over 17%; Here Are 20 Stocks Moving Premarket (Benzinga)
|
|
|
ZVRA up in pre-market trading on better-than-expected Q4 results. Gainers include BRTX, COOT, BIYA, SOAR, MTEN, MDCX, NXGL, ABTC, and VALN. Losers include GSIW, POM, ARQ, RAIL, and NTZ.
Importance Rank:
1
read more...
|
|
|
|
|
|